Sana is a Washington-based biotechnology company that develops and commercializes gene cell therapies for the treatment of unmet diseases.
Business Model:
Revenue: $0
Employees: 201-500
Address: 188 East Blaine Street
City: Seattle
State: WA
Zip: 98102
Country: US
Sana is a Washington-based biotechnology company that develops and commercializes gene cell therapies for the treatment of unmet diseases.
Contact Phone:
+12067017914
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
2/4/2021
IPO Valuation:
$6B
Ticker Symbol:
SANA
IPO Price:
$25/share
Amount Raised:
$588M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|---|---|
10/2020 | Oscine Therapeutics |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|